Research Letter
Adalimumab for severe psoriasis in Chilean paediatric patients
Lido
6927
Vezesque se leu este artigo
3047
Total PDF
3880
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 6 | 29 | 13 | 42 |
| 2025 5 | 152 | 64 | 216 |
| 2025 4 | 164 | 40 | 204 |
| 2025 3 | 168 | 55 | 223 |
| 2025 2 | 128 | 68 | 196 |
| 2025 1 | 108 | 51 | 159 |
| 2024 12 | 101 | 36 | 137 |
| 2024 11 | 113 | 55 | 168 |
| 2024 10 | 110 | 68 | 178 |
| 2024 9 | 133 | 81 | 214 |
| 2024 8 | 150 | 106 | 256 |
| 2024 7 | 137 | 115 | 252 |
| 2024 6 | 93 | 60 | 153 |
| 2024 5 | 88 | 57 | 145 |
| 2024 4 | 116 | 81 | 197 |
| 2024 3 | 96 | 68 | 164 |
| 2024 2 | 98 | 73 | 171 |
| 2024 1 | 93 | 43 | 136 |
| 2023 12 | 70 | 72 | 142 |
| 2023 11 | 99 | 66 | 165 |
| 2023 10 | 59 | 63 | 122 |
| 2023 9 | 77 | 53 | 130 |
| 2023 8 | 43 | 34 | 77 |
| 2023 7 | 71 | 40 | 111 |
| 2023 6 | 66 | 41 | 107 |
| 2023 5 | 48 | 21 | 69 |
| 2023 4 | 28 | 15 | 43 |
| 2023 3 | 52 | 41 | 93 |
| 2023 2 | 38 | 28 | 66 |
| 2023 1 | 39 | 34 | 73 |
| 2022 12 | 30 | 21 | 51 |
| 2022 11 | 46 | 46 | 92 |
| 2022 10 | 43 | 52 | 95 |
| 2022 9 | 39 | 45 | 84 |
| 2022 8 | 31 | 37 | 68 |
| 2022 7 | 35 | 41 | 76 |
| 2022 6 | 35 | 51 | 86 |
| 2022 5 | 31 | 49 | 80 |
| 2022 4 | 40 | 45 | 85 |
| 2022 3 | 36 | 61 | 97 |
| 2022 2 | 29 | 31 | 60 |
| 2021 1 | 40 | 80 | 120 |
| 2021 12 | 38 | 52 | 90 |
| 2021 11 | 34 | 60 | 94 |
| 2021 10 | 47 | 66 | 113 |
| 2021 9 | 30 | 41 | 71 |
| 2021 8 | 40 | 51 | 91 |
| 2021 7 | 29 | 33 | 62 |
| 2021 6 | 42 | 48 | 90 |
| 2021 5 | 50 | 66 | 116 |
| 2021 4 | 177 | 237 | 414 |
| 2021 3 | 53 | 60 | 113 |
| 2021 2 | 17 | 12 | 29 |
| 2020 1 | 20 | 16 | 36 |
| 2020 12 | 17 | 22 | 39 |
| 2020 11 | 12 | 10 | 22 |
| 2020 10 | 10 | 12 | 22 |
| 2020 9 | 12 | 10 | 22 |
| 2020 8 | 9 | 8 | 17 |
| 2020 7 | 11 | 11 | 22 |
| 2020 6 | 10 | 10 | 20 |
| 2020 5 | 12 | 11 | 23 |
| 2020 4 | 1 | 1 | 2 |
| 2020 3 | 7 | 4 | 11 |
| 2020 1 | 0 | 5 | 5 |
Mostrar tudo
